title: Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia.
abstract: OBJECTIVE
  The aims of this study were to correlate beta-endorphin plasma levels and anginal pain in patients with ischemia induced by percutaneous transluminal coronary angioplasty and to detect eventual endorphin variations during balloon occlusion.
  
  
  BACKGROUND
  The opioid system appears involved in the absence of pain occurring in silent myocardial ischemia.
  
  
  METHODS
  Beta-endorphin plasma levels were measured 24 h before, just before, during and after coronary angioplasty (performed on the left anterior descending artery) in 53 men with documented coronary artery disease and exercise-induced myocardial ischemia.
  
  
  RESULTS
  Group 1 (33 patients) reported symptoms; group 2 (20 patients) was asymptomatic during angioplasty. In these patients, the prevalence of exercise-induced silent ischemia was 57%. The occurrence of angina during exercise or angioplasty was related to the frequency of angina during daily life when patients were subgrouped. The severity and distribution of coronary artery disease did not differ between the two groups. During angioplasty, the number of balloon inflations and the inflation time and pressure were similar in symptomatic and asymptomatic patients. In each group, no short-term variability of baseline beta-endorphin plasma levels was observed during 2 consecutive days. Corresponding beta-endorphin plasma levels (at baseline and during and after angioplasty) were significantly higher in Group 2. During balloon occlusion, the levels decreased significantly in the symptomatic group at the onset of angina but remained stable in the asymptomatic group.
  
  
  CONCLUSIONS
  Methodologic variables and the severity of coronary artery disease did not influence the presence of symptoms during angioplasty-induced ischemia. Beta-endorphin plasma levels were higher and more stable in patients with silent ischemia during angioplasty, suggesting that opiate levels and their variation during ischemia are associated with individual attitude toward anginal pain.
authors.affiliation: Department of Internal Medicine, University Hospital, Pavia, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Falcone
authors.forename: L
authors.initials: L
authors.lastname: Guasti
authors.forename: M
authors.initials: M
authors.lastname: Ochan
authors.forename: S
authors.initials: S
authors.lastname: Codega
authors.forename: M
authors.initials: M
authors.lastname: Tortorici
authors.forename: L
authors.initials: L
authors.lastname: Angoli
authors.forename: R
authors.initials: R
authors.lastname: Bergamaschi
authors.forename: C
authors.initials: C
authors.lastname: Montemartini
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000787:Angina Pectoris / Q000097:blood* / Q000209:etiology; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D005080:Exercise Test; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood* / Q000628:therapy; D015995:Prevalence; D013997:Time Factors; D001615:beta-Endorphin / Q000097:blood*
chemical_list: D001615:beta-Endorphin